Daniel L. Alkon - Jun 4, 2021 Form 3 Insider Report for Synaptogenix, Inc. (SNPX)

Role
Chief Scientific Officer, Director
Signature
/s/ Daniel L. Alkon
Stock symbol
SNPX
Transactions as of
Jun 4, 2021
Transactions value $
$0
Form type
3
Date filed
6/14/2021, 08:15 PM
Next filing
Jun 16, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SNPX Common Stock, par value $0.0001 per share 1.48K Jun 4, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SNPX Stock Option (Right to Buy) Jun 4, 2021 Common Stock, par value $0.0001 per share 31.3K $9.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The holder's options become exercisable as follows: (i) 50% of the options shall become exercisable immediately on January 13, 2021 and (ii) 50% of the options shall become exercisable upon the holder's completion of one year of service following January 13, 2021.